Lisata Therapeutics (LSTA) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to -$4.2 million.
- Lisata Therapeutics' Profit After Tax rose 1381.34% to -$4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 million, marking a year-over-year increase of 1204.44%. This contributed to the annual value of -$20.0 million for FY2024, which is 410.27% up from last year.
- According to the latest figures from Q3 2025, Lisata Therapeutics' Profit After Tax is -$4.2 million, which was up 1381.34% from -$4.7 million recorded in Q2 2025.
- In the past 5 years, Lisata Therapeutics' Profit After Tax registered a high of -$4.0 million during Q2 2023, and its lowest value of -$6.2 million during Q1 2023.
- For the 3-year period, Lisata Therapeutics' Profit After Tax averaged around -$5.0 million, with its median value being -$4.9 million (2024).
- Over the last 5 years, Lisata Therapeutics' Profit After Tax had its largest YoY gain of 1407.27% in 2024, and its largest YoY loss of 2525.45% in 2024.
- Over the past 3 years, Lisata Therapeutics' Profit After Tax (Quarter) stood at -$5.4 million in 2023, then increased by 14.07% to -$4.6 million in 2024, then grew by 7.83% to -$4.2 million in 2025.
- Its Profit After Tax was -$4.2 million in Q3 2025, compared to -$4.7 million in Q2 2025 and -$4.7 million in Q1 2025.